| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018384178 |
| P356 | DOI | 10.1038/SJ.BJC.6602123 |
| P932 | PMC publication ID | 2409941 |
| P698 | PubMed publication ID | 15381927 |
| P5875 | ResearchGate publication ID | 8332895 |
| P2093 | author name string | J C Becker | |
| W Lieb | |||
| E-B Bröcker | |||
| C S Vetter | |||
| P2860 | cites work | Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB | Q22009950 |
| Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA | Q22010440 | ||
| Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells | Q24290869 | ||
| Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family | Q24291540 | ||
| Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium | Q24318429 | ||
| Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70 | Q24612004 | ||
| Mutations of the BRAF gene in human cancer | Q27860760 | ||
| Activation of heat shock factor by alkylating agents is triggered by glutathione depletion and oxidation of protein thiols | Q30423743 | ||
| HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story | Q33594187 | ||
| Immunotherapy of uveal melanoma | Q33812792 | ||
| The HLA crossroad in tumor immunology | Q33829869 | ||
| Uveal melanoma: natural history and treatment options for metastatic disease. | Q33830987 | ||
| MIC genes: from genetics to biology | Q34082781 | ||
| MICA and MICB genes: can the enigma of their polymorphism be resolved? | Q34295071 | ||
| HLA expression in uveal melanoma: there is no rule without some exception | Q34662383 | ||
| HLA class I antigen loss, tumor immune escape and immune selection | Q35023518 | ||
| HLA-G and MIC expression in tumors and their role in anti-tumor immunity | Q35053398 | ||
| Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis | Q35234747 | ||
| HLA expression in a primary uveal melanoma, its cell line, and four of its metastases | Q35298749 | ||
| Treatment of metastatic uveal melanoma: review and recommendations | Q36130137 | ||
| Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes | Q36641299 | ||
| Survivin expression in oral squamous cell carcinoma. | Q36673589 | ||
| High resolution molecular phototyping of MICA and MICB alleles using sequence specific primers | Q38363688 | ||
| Association of HLA class I and class II antigen expression and mortality in uveal melanoma | Q38459880 | ||
| Missing HLA class I expression on Daudi cells unveils cytotoxic and proliferative responses of human gammadelta T lymphocytes | Q40715241 | ||
| Natural history of HLA expression during tumour development. | Q40797268 | ||
| Transforming growth factor-beta down-regulates major histocompatibility complex class I antigen expression and increases the susceptibility of uveal melanoma cells to natural killer cell-mediated cytolysis | Q41292345 | ||
| Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. | Q41372824 | ||
| Malignant melanoma: modern black plague and genetic black box. | Q41484395 | ||
| Lack of BRAF mutation in primary uveal melanoma. | Q47807462 | ||
| Screening for metastatic malignant melanoma of the uvea revisited. | Q50639472 | ||
| Double jeopardy: Ras and CDK4 co-expression in skin cancer | Q57002200 | ||
| Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma | Q57002206 | ||
| Human leukocyte antigen class I expression. Marker of poor prognosis in uveal melanoma | Q73671830 | ||
| Mutation analysis of the PTEN gene in uveal melanoma cell lines | Q73911344 | ||
| Expression of stress-induced MHC class I related chain molecules on human melanoma | Q77834581 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1495-1499 | |
| P577 | publication date | 2004-10-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Loss of nonclassical MHC molecules MIC-A/B expression during progression of uveal melanoma | |
| P478 | volume | 91 |
| Q38180339 | Advances in NKG2D ligand recognition and responses by NK cells |
| Q37559284 | Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells |
| Q35079709 | Biology of advanced uveal melanoma and next steps for clinical therapeutics |
| Q44124507 | Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer |
| Q39614809 | Differential mechanisms of shedding of the glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands |
| Q37764003 | Effect of NKG2D ligand expression on host immune responses |
| Q48092810 | Expression of natural killer cell regulatory microRNA by uveal melanoma cancer stem cells. |
| Q92029916 | IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma |
| Q37535138 | Immune escape mechanisms of intraocular tumors |
| Q37500476 | Immune oppression array elucidating immune escape and survival mechanisms in uveal melanoma |
| Q92256915 | Immunological Backbone of Uveal Melanoma: Is There a Rationale for Immunotherapy? |
| Q36615048 | Inflammation in uveal melanoma |
| Q34131549 | Interleukin 10 decreases MICA expression on melanoma cell surface |
| Q37592694 | MICA Expression Is Regulated by Cell Adhesion and Contact in a FAK/Src-Dependent Manner. |
| Q38202957 | Molecular Bases for the Regulation of NKG2D Ligands in Cancer. |
| Q86205811 | NKG2D Ligands in Cancer Immunotherapy: Target or Not? |
| Q88016001 | NKG2D and its ligands in cancer |
| Q26771449 | Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy |
| Q37143139 | Natural killer cell-directed therapies: moving from unexpected results to successful strategies |
| Q42200330 | Ocular immune privilege and ocular melanoma: parallel universes or immunological plagiarism? |
| Q42688261 | Prognostic value of soluble major histocompatibility complex class I polypeptide-related sequence A in non-small-cell lung cancer - significance and development. |
| Q36900826 | Promiscuity and the single receptor: NKG2D. |
| Q37357720 | Proteasome regulation of ULBP1 transcription |
| Q39939991 | Redirecting NK cells mediated tumor cell lysis by a new recombinant bifunctional protein. |
| Q34368956 | Regulation and gene expression profiling of NKG2D positive human cytomegalovirus-primed CD4+ T-cells |
| Q89511646 | The Role of Immune Checkpoint Blockade in Uveal Melanoma |
| Q37742632 | The biology of uveal melanoma |
| Q60345328 | The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia |
| Q36896195 | Tumor immunoediting and immunosculpting pathways to cancer progression. |
Search more.